FMSのチャート
FMSの企業情報
| symbol | FMS |
|---|---|
| 会社名 | Fresenius Medical Care AG_Co KGaA （FRESENIUS MEDCL） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | フレゼニウス・メディカル・ケア（Fresenius Medical Care AG_Co. KGaA）は末期腎疾患（ESRD）の治療向けに透析ケアと透析製品の分野で事業を展開するドイツの腎臓透析会社である。同社の透析事業は垂直統合型で、自社所有の透析診療室で透析治療を提供するうえ、これらの透析診療室に各種な製品を供給するという全体の透析バリューチェーンに製品とサービスを提供する。同社は血液透析(HD)と腹膜透析（PD）という2種類の透析治療を提供する。HDにおいて、機械は特殊なフィルター、透析器を介して患者の血液をコントロールする。PDにおいて、患者の腹膜は透析膜として使用される。同社の製品ポートフォリオは、慢性血液透析透析、在宅透析、腎医薬品、救急治療、肝臓サポート、治療アフェレーシス、サポート療法及び水技術などを含む。そのほか、同社はその他の透析サービスプロバイダ向けに透析製品を販売する。 フレゼニウス・メディカル・ケアはドイツを拠点に腎臓透析関連製品と治療サ―ビスを展開。世界に外来診療所を所有し、血液透析、関連検査、診断サ―ビス、在宅透析、旅行先透析サ―ビスを提供。また、透析医療施設に透析関連製品を販売。米国ではスペクトラル・ラボラトリ―ズを通じ、臨床検査サ―ビスを展開。病院と契約し、入院患者に透析やその他サ―ビスを提供。 Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services. |
| 本社所在地 | Else-Kroener-Strasse 1 Bad Homburg 61352 DEU |
| 代表者氏名 | Dieter Schenk |
| 代表者役職名 | Chairman of the Supervisory Board |
| 電話番号 | +49 6172-6090 |
| 設立年月日 | 35278 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 112658人 |
| url | www.fmc-ag.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） 3215.27900 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 25440.83000 |
| 売上高 | （百万ドル） 18555.71000 |
| 企業価値(EV) | （百万ドル） 31497.07500 |
| 当期純利益 | （百万ドル） 2222.53600 |
| 決算概要 | BRIEF: For the fiscal year ended 31 December 2018 Fresenius Medical Care AG_Co. (ADR) revenues decreased 7% to EUR16.55B. Net income increased 55% to EUR1.98B. Revenues reflect North America segment decrease of 10% to EUR11.57B Latin America segment decrease of 5% to EUR686.5M Corporate / Eliminations segment remaining flat at EUR14.7M North America segment decrease of 10% to EUR11.57B Germany segment decrease of 2% to EUR426.3M. |
FMSのテクニカル分析
FMSのニュース
Fresenius: Q4 Earnings Snapshot 2023/02/22 19:16:03 WTOP
BAD HOMBURG, Germany (AP) — BAD HOMBURG, Germany (AP) — Fresenius Medical Care AG (FMS) on Tuesday reported fourth-quarter earnings…
Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Call Transcript 2023/02/22 17:37:04 Seeking Alpha
Fresenius Medical Care AG & Co. KGaA (NYSE:NYSE:FMS) Q4 2022 Earnings Conference Call February 22, 2023 9:30 AM ETCompany ParticipantsDominik Heger - Head, Investor RelationsHelen Giza…
Fresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies Structure 2023/02/22 15:08:49 Benzinga
Fresenius Medical Care AG & Co (NYSE: FMS ) has implemented its new operating model with two global segments: Care Enablement (Health Care Products) and Care Delivery (Health Care Services), along with portfolio adjustment. In Care Delivery, the company will exit unsustainable markets and divest non-core businesses. In Care Enablement, it will rationalize its global R&D programs and evaluate the divestment of non-core products. The company will strictly follow its policy to align dividend payments with earnings development. This year''s dividend proposal of €1.12 reflects a reduction … Full story available on Benzinga.com
Fresenius Medical Care AG & Co. KGaA 2022 Q4 - Results - Earnings Call Presentation (NYSE:FMS) 2023/02/22 14:58:19 Seeking Alpha
The following slide deck was published by Fresenius Medical Care AG & Co.
Fresenius Medical Care AG - Consensus Indicates Potential .6% Upside - DirectorsTalk Interviews 2023/02/22 12:33:59 DirectorsTalk
Fresenius Medical Care AG - Consensus Indicates Potential .6% Upside
EQS-DD: Fresenius Medical Care AG & Co. KGaA: Rice Powell, buy 2022/12/07 15:44:54 Wallstreet:Online
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 07.12.2022 / 16:43 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated
EQS-DD: Fresenius Medical Care AG & Co. KGaA (deutsch) Von dpa-AFX 2022/12/07 15:44:00 Investing.com Germany
EQS-DD: Fresenius Medical Care AG & Co. KGaA (deutsch)
CMA CGM to acquire flagship terminals in the Port of New York and New Jersey 2022/12/07 00:27:00 Kwhen Finance
FMC boss leaves after two months as Fresenius pushes for changes 2022/12/06 13:45:50 Reuters
German dialysis specialist Fresenius Medical Care''s (FMC) Chief Executive Carla Kriwet stepped down on Monday, marking the second leadership change in as many months as parent Fresenius pushes for a faster overhaul of the struggling unit.
FMC boss leaves after two months as Fresenius pushes for fast changes 2022/12/06 12:19:54 Financial Post
BENGALURU/MUNICH — German dialysis specialist Fresenius Medical Care’s (FMC) Chief Executive Carla Kriwet stepped down on Monday, marking the second leadership change in as many months as parent Fresenius pushes for faster at the struggling unit. FMC late on Monday said Kriwet, who had taken over as CEO on Oct. 1, had decided to leave […]
FMC boss leaves after two months as Fresenius pushes for fast changes 2022/12/06 12:19:54 Financial Post
BENGALURU/MUNICH — German dialysis specialist Fresenius Medical Care’s (FMC) Chief Executive Carla Kriwet stepped down on Monday, marking the second leadership change in as many months as parent Fresenius pushes for faster at the struggling unit. FMC late on Monday said Kriwet, who had taken over as CEO on Oct. 1, had decided to leave […]
Fresenius Medical Care CFO takes over as CEO amid focus on ''operational turnaround'' 2022/12/06 09:39:52 Seeking Alpha
Fresenius Medical Care (FMS) appointed Helen Giza as CEO, with immediate effect, about a month after the company cut its 2022 outlook and it was reported that activist investor…
Germany’s FMC appoints Helen Giza as CEO 2022/12/05 23:21:55 FX Empire
(Reuters) – German dialysis specialist Fresenius Medical Care (FMC) on Monday said its Chief Executive Carla Kriwet would step down just two months after taking over and will be replaced by Helen Giza.
EQS-Adhoc: Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company 2022/12/05 22:40:52 Wallstreet:Online
EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Personnel Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company 05-Dec-2022 / 23:40 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible
EQS-News: Fresenius Medical Care AG & Co. KGaA: Helen Giza to take over as Chief Executive Officer of Fresenius Medical Care 2022/12/05 22:39:47 Wallstreet:Online
EQS-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel Fresenius Medical Care AG & Co. KGaA: Helen Giza to take over as Chief Executive Officer of Fresenius Medical Care 05.12.2022 / 23:39 CET/CEST The issuer is solely responsible for the content of this announcement. Helen Giza (54) has been appointed Chief Executive